Forbion related stories
All articles and analysis
German biopharma company Omeicos Therapeutics snags Series C fundingBerlin-based Omeicos Therapeutics, a biopharmaceutical company, has secured 17 million euros in Series C funding. Forbion led the round.
- Milestone Pharmaceuticals amasses $80 mln
Montreal-based Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing interventions for tachycardias, has closed $80 million in financing. RTW Investments LP led the round with participation from other investors that included Venrock Healthcare Capital Partners, Boxer Capital of Tavistock Group, Novo Holdings A/S, Forbion, funds managed by Tekla Capital Management LLC, Domain Associates, BDC Capital, Pappas Capital, GO Capital and Fonds de solidarité FTQ.
Milestone Pharmaceuticals secures $105 mln in RTW-led roundMontréal-based cardiovascular drug developer Milestone Pharmaceuticals has raised $80 million in its latest financing. U.S. life sciences investment firm RTW Investments led the round. It was joined by other new investors, including Venrock Healthcare Capital Partners and Tavistock Group, and existing investors, including Novo Holdings A/S, Forbion Capital Partners, Tekla Capital Management, Domain Associates, BDC Capital, Pappas Capital, GO Capital and Fonds de solidarité FTQ. Milestone will use the funds raised for its Phase 3 clinical program, pre-launch activities of etripamil, a new drug for treating paroxysmal supraventricular tachycardia, and expanding its pipeline. Led by President and CEO Joseph Oliveto, Milestone closed a $68 million Series C round /canada/2017/08/3465587/ last year.
US steps up as European LPs 'strike’ over BrexitUK private equity funds are under increased scrutiny from continental investors but US LPs seem to have fewer doubts.
- Forbion Fund IV raises 270 mln euros
Forbion said July 11 that its fourth flagship fund closed on 270 million euros ($316.3 million), surpassing its 250 million euros target. Forbion IV will focus on biotech and seek to invest in about 15 companies, mainly in the EU and UK.
Forbion increases bite size after first close – exclusiveThe Dutch VC firm held a first close on €270m for Fund IV this week just two months after launch, managing partner Sander Slootweg told PEI.